Skip to main content

ADVERTISEMENT

Dinesh Arab, MD

Original Contribution
08/01/2008
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist regarding the optimal dose of acetyl salicylic acid (ASA) to be given after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). The Seventh ACCP Conference on Antithrombotic and Thrombolytic...
Conflicting opinions exist...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have been tremendous advancements in the technique and procedural success rates in the field of interventional cardiology. Many of these advancements have addressed percutaneous coronary interventions (PCI) on...
Over the past decade there have...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Coronary artery perforation (CP) is a rare and potentially life-threatening complication of percutaneous coronary intervention (PCI). CP has historically been reported to occur in 0.1–3.0% of PCI procedures.1–5 Although CP can be caused by...
Coronary artery perforation (CP) is a rare and potentially life-threatening complication of percutaneous coronary intervention (PCI). CP has historically been reported to occur in 0.1–3.0% of PCI procedures.1–5 Although CP can be caused by...
Coronary artery perforation (CP)...
08/01/2008
Journal of Invasive Cardiology